The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.
To view completed FDA-TRACK performance measures and projects view the Archive Index
Number of results: 10
|Item||Program||Office||Strategic Plan||Strategic Goal/Area|
|1||Maintain timeliness of payments to vendors per HHS mandates||OPERATIONS||Office of Finance, Budget, and Acquisition||N/A||N/A|
|2||Maintain compliance with the Department of Treasury and HHS' policies and strategies for managing FDA's accounts receivables||OPERATIONS||Office of Finance, Budget, and Acquisition||N/A||N/A|
|3||Monitor contracts awarded to small businesses to ensure annual targets are met||OPERATIONS||Office of Finance, Budget, and Acquisition||N/A||N/A|
|4||Monitor contracts competed over the micro-purchase threshold ($3K) to ensure HHS mandates are met||OPERATIONS||Office of Finance, Budget, and Acquisition||N/A||N/A|
|5||Consolidation of Life Sciences-Biodefense Complex to White Oak||OPERATIONS||Office of Facilities, Engineering, and Mission Support Services||N/A||N/A|
|6||Maintain number of Personal Identification Verification (PIV) Cards issued annually||OPERATIONS||Office of Security Operations||N/A||N/A|
|7||Discrimination complaint timeliness measures ||OPERATIONS||Office of Equal Employment Opportunity||N/A||N/A|
|8||Promote equality, fairness, understanding and acceptance of diversity at the FDA||OPERATIONS||Office of Equal Employment Opportunity||N/A||N/A|
|9||Diversity Council Enhancement Project||OPERATIONS||Office of Equal Employment Opportunity||N/A||N/A|
|10||Ensure 90% of all FDA Information Systems have a valid Authority to Operate (ATO) for the fiscal year||OPERATIONS||Office of Information Management||N/A||N/A|
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.